PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
29-Aug-2024 Leqembi® (lecanemab) Authorised for Early Alzheimer’s Disease in Great Britain Eisai Europe, Ltd
27-Aug-2024 BioPhorum acquires training organization Brookwood Global BioPhorum
27-Aug-2024 Leadership Appointments at RQM+ RQM+
27-Aug-2024 ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse ConTIPI Medical Ltd
27-Aug-2024 European Commission approves Celltrion’s SteQeyma® (CT-P43), a biosimilar to Stelara® (ustekinumab), for the treatment of multiple chronic inflammatory diseases Celltrion
27-Aug-2024 UCB to Accelerate Innovation and Strategic Partnerships, Divesting Mature Product Portfolio in China UCB
27-Aug-2024 Medigene AG implements announced 2:1 share capital reduction and consolidation of the shares effective August 29, 2024 Medigene AG
27-Aug-2024 RedHill’s Opaganib Granted Orphan Drug Designation by the FDA for Childhood Cancer, Neuroblastoma RedHill Biopharma
27-Aug-2024 ENA Respiratory Progresses Phase Ib Study of its Dry Powder Formulation of Intranasal Innate Immunomodulator INNA-051 ENA Respiratory
27-Aug-2024 InsightRX Announces the release of InsightRX GEMINI(SM) InsightRX
22-Aug-2024 Unaudited Interim Results for the six months ended 30 June 2024 Cambridge Cognition Holdings plc
22-Aug-2024 Hevolution Foundation and Dolby Family Ventures join Vandria’s 2nd Series A closing, bringing the total round to $30.7M (CHF 28.3M) to Progress the Mitophagy Inducer VNA-318 into CNS Clinical Development Vandria SA
22-Aug-2024 Blue Earth Therapeutics Ltd Announces Expansion of Partnership With Seibersdorf Labor GmbH to Include Manufacture of Therapeutic Radiopharmaceutical, 225Ac-rhPSMA-10.1 Blue Earth Therapeutics Ltd
22-Aug-2024 London BioScience Innovation Centre welcomes Baseimmune Ltd to its new fully fitted grow-on lab space within the Apex Building London BioScience Innovation Centre
22-Aug-2024 RedHill Announces Positive Obesity and Diabetes Results with Opaganib RedHill Biopharma
22-Aug-2024 Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor Adcendo ApS and Multitude Therapeutics Inc
20-Aug-2024 Pen Needles Market Size to Reach USD 3.5 Billion by 2029, Says The Maximize Market Research. Maximize Market Research Pvt. Ltd.
16-Aug-2024 CV6 Therapeutics Announces Initiation of Patient Dosing in Phase 1a Clinical Trial Evaluating the Investigational First-In-Class, Specific dUTPase Inhibitor CV6-168 CV6 Therapeutics
15-Aug-2024 Phastar named in 2024 Environment 100 List Phastar
14-Aug-2024 OrganaBio Manufactures First GMP Cryopreserved Leukopaks for Two New Biopharma Partners’ Allogeneic Cell Therapies OrganaBio